Lab-Grown tumor clones could guide cancer therapy

NCT ID NCT04261192

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to grow miniature versions of head and neck tumors, called organoids, from patient samples. Researchers will test different cancer drugs on these organoids to see which ones work best. The goal is to eventually use this approach to tailor treatments to each patient, potentially improving outcomes and reducing side effects. The study involves 120 adults with advanced squamous cell carcinoma of the head and neck who are scheduled for surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a lab test that helps doctors choose the most effective treatment for each patient, reducing unnecessary side effects.
What could go wrong
This is an early-stage study focused on building organoids, not testing treatments on people. It may not lead to immediate changes in patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU de Caen

    RECRUITING

    Caen, France

    Contact

    Contact Email: •••••@•••••

  • Centre François Baclesse

    RECRUITING

    Caen, 14076, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.